Vimarsana
Biggest News Aggregation in the World

Page 46 - Work Productivity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Work Productivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Work Productivity Today - Breaking & Trending Today

LXB improves functional outcomes in patients with idiopathic hypersomnia - Vimarsana News

LXB improves functional outcomes in patients with idiopathic hypersomnia

LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.The treatment (calcium, magnesium, potassium and sodium oxybates; Jazz Pharmaceuticals Inc.), also referred to as lower-sodium oxybate (LXB) and Xywav, has the same active moiety at the same concentration as

Source: healio.com
Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress - Vimarsana News

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress

Investegate announcements from Galapagos NV, Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress

"What is wellbeing? An examination of the World Health Organisation's d" by Bevan John Nicholas - Vimarsana News

"What is wellbeing? An examination of the World Health Organisation's d" by Bevan John Nicholas

In 2018, depression was ranked as the leading burden of disease worldwide, affecting 4.4% of the world’s population. One of the highest at-risk groups for depression is university students. In Australia, around 84% of university students report elevated levels of depressive symptoms, approximately three times higher than that of age matched peers in the general population. It is hypothesised that a dual focus of symptom prevention and wellbeing promotion may be the most effective way to reduce symptoms of depression. The World Health Organisation defines wellbeing as a state in which an indi...

Source: uow.edu.au
Chiasma to Present Encore and New Data from MPOWERED™ Phase - Vimarsana News

Chiasma to Present Encore and New Data from MPOWERED™ Phase

-- New clinical data accepted for oral and e-Poster presentation at AACE -- -- e-ECE clinical data previously presented at Endocrine Society’s 2021...

Chiasma Presents Positive Patient-Reported Outcomes Data from its MPOWERED™ Phase 3 Trial Comparing MYCAPSSA® to Long-Acting Injectables for the Maintenance Treatment of Adults with Acromegaly - Vimarsana News

Chiasma Presents Positive Patient-Reported Outcomes Data from its MPOWERED™ Phase 3 Trial Comparing MYCAPSSA® to Long-Acting Injectables for the Maintenance Treatment of Adults with Acromegaly

Message : Required fields NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported significantly improved quality of life and work productivity after transitioning from long-acting injectable somatostatin analogs (iSSAs) to MYCAPSSA ®. The data were shared as an oral presentation at the 30 th Annual American Association of Clinical Endocrinology (AACE) Meeting being held virtually from ...